Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Capital Expenditures

Amneal Pharmaceuticals Inc Capital Expenditures Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Capital Expenditures from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Capital Expenditures for the quarter ending December 12, 2018 was $-20m a 2.62% decrease of -1m year over year
  • Amneal Pharmaceuticals Inc Capital Expenditures for the last 12 months ending December 12, 2018 was $-83m a -7.73% increase of 6m year over year
  • Amneal Pharmaceuticals Inc Annual Capital Expenditures for 2018 was $-83m a -14.06% increase of 12m from 2017
  • Amneal Pharmaceuticals Inc Annual Capital Expenditures for 2017 was $-95m a -29.53% increase of 28m from 2016
  • Amneal Pharmaceuticals Inc Annual Capital Expenditures for 2016 was $-123m a 4.38% decrease of -5m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Capital Expenditures Data

12/2018$-20m
09/2018$-26m
06/2018$-17m
03/2018$-19m
12/2017$-25m
09/2017$-16m
06/2017$-30m
03/2017$-25m
12/2016$-31m

Annual AMRX Capital Expenditures Data

2018$-83m
2017$-95m
2016$-123m
2015$-117m
2014$-79m